| Utestående aktier | 4,271,759 shares |
| Insideraktier | 12 138 101 shares |
| Totalt antal insynspersoner | 49 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
0.000 %( )
3338 out of 11218Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Histogen Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Advent Venture Partners Llp
10% Owner -
|
2 166 836 | 2 166 836 | |
| Aberdare GP III, L.L.C. - | 0 | 0 | |
|
Aberdare Partners III LP
10% Owner -
|
0 | 0 | |
|
Aberdare Ventures III LP
10% Owner -
|
0 | 0 | |
| Burgess Gary C. Sr. VP, Clin. Res. & CMO - [O] | 121 212 | 121 212 | |
|
Cooperative Gilde Healthcare Ii U.a.
10% Owner -
|
1 487 320 | 1 487 320 | |
| Charles Cashion SVP, Finance, CFO and Sec. - [O] | 42 424 | 42 424 | |
| Stephen Chang Director - [D] | 14 485 | 724 | |
| David Hugh Crean | 25 000 | ||
| Moya Daniels | 100 000 | ||
|
Luke Evnin
10% Owner -
|
1 192 080 | 1 192 080 | |
|
Todd Foley
10% Owner -
|
1 192 080 | 1 192 080 | |
|
Ansbert Gadicke
10% Owner -
|
1 192 080 | 1 192 080 | |
| David F Hale Director - [D] | 24 242 | 24 242 | |
| David T Hagerty | 175 000 | ||
|
Jonathan Jackson
Director, 10% Owner -
[D]
|
2 356 597 | 117 830 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
Vaughn M Kailian
10% Owner -
|
1 192 080 | 1 192 080 | |
| Daniel L Kisner Director - [D] | 5 455 | 5 455 | |
| Paul H Klingenstein Director - [D] | 8 731 | 8 731 | |
| Preston Klassen | 20 000 | ||
| Knudson Susan A. | 169 800 | ||
| Louis P Lacasse Director - [D] | 809 887 | 809 887 | |
| William R Larue | 20 000 | ||
| Martin Latterich See Remarks - [O] | 11 951 | 598 | |
|
Mpm Asset Management Investors Bv5 Llc
10% Owner -
|
1 192 080 | 1 192 080 | |
|
MPM Asset Management Investors BV4 LLC
10% Owner -
|
1 192 080 | 1 192 080 | |
|
Mpm Bioventures V Gp Llc
10% Owner -
|
1 192 080 | 1 192 080 | |
|
Mpm Bioventures V Llc
10% Owner -
|
1 192 080 | 1 192 080 | |
|
Mpm Bioventures V, L.p.
10% Owner -
|
1 192 080 | 1 192 080 | |
|
MPM BioVentures IV GP LLC
10% Owner -
|
1 192 080 | 1 192 080 | |
|
MPM BioVentures IV GmbH & Co. Beteiligungs KG
10% Owner -
|
1 192 080 | 1 192 080 | |
|
MPM BioVentures IV LLC
10% Owner -
|
1 192 080 | 1 192 080 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
|
MPM BioVentures IV QP LP
10% Owner -
|
1 192 080 | 1 192 080 | |
|
Shahzad Malik
Director, 10% Owner -
[D]
|
2 166 836 | 2 166 836 | |
| Keith W Marshall EVP, COO & CFO - [O] | 19 885 | 1 326 | |
| Steven J Mento Director - [D] | 39 572 | 2 638 | |
| Gail K Naughton See Remarks - [O] | 426 526 | 21 326 | |
| Richard W Pascoe President, CEO & Director, Director - [D] [O] | 30 000 | 1 500 | |
|
Marc Olivier Perret
Director, 10% Owner -
[D]
|
1 487 320 | 1 487 320 | |
| Ripley Daniel L. SVP, Bus Dev, P&A Mgmt - [O] | 32 431 | 32 431 | |
| Brian Satz Director - [D] | 1 434 | 72 | |
| James Paul Scopa Director - [D] | 1 192 080 | 1 192 080 | |
| Scott Kathleen D. | 30 000 | ||
| Edward F III Smith SVP, Reg Affairs and QA - [O] | 10 875 | 10 875 | |
| Spada Alfred P. See Remarks - [O] | 1 235 | 1 235 | |
| Michelle L Vandertie Vice President, Finance - [O] | 2 813 | 2 813 | |
| Wart Harold Van Director - [D] | 18 181 | 18 181 | |
|
Vort John Vander
10% Owner -
|
1 192 080 | 1 192 080 | |
| Yizhuo Zhang Director - [D] | 600 983 | 30 049 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i HSTOQ / Histogen Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i HSTOQ / Histogen Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-03 | 3 | Spada Alfred P. | HSTO | Common Stock | I | 1 235 | ||||||||
| 2023-02-03 | 3 | Spada Alfred P. | HSTO | Common Stock | D | 979 | ||||||||
| 2022-02-25 | 2022-02-24 | 4 | Mento Steven J | HSTO | Stock Option (right to buy) | D | 0,24 | 151 642 | 151 642 | |||||
| 2022-02-22 | 2022-02-17 | 4 | Knudson Susan A. | HSTO | Stock Option (right to buy) | D | 0,24 | 169 800 | 169 800 | |||||
| 2022-02-22 | 2022-02-17 | 4 | Latterich Martin | HSTO | Stock Option (right to buy) | D | 0,24 | 134 900 | 134 900 | |||||
| 2021-11-10 | 2021-11-08 | 4 | Latterich Martin | HSTO | Restricted Stock Unit | D | 102 880 | 102 880 | ||||||
| 2021-11-10 | 2021-11-08 | 4 | Mento Steven J | HSTO | Restricted Stock Unit | D | 228 395 | 228 395 | ||||||
| 2021-11-10 | 2021-11-08 | 4 | Mento Steven J | HSTO | Stock Option (right to buy) | D | 0,73 | 377 830 | 377 830 | |||||
| 2021-11-10 | 2021-11-08 | 4 | Knudson Susan A. | HSTO | Restricted Stock Unit | D | 137 174 | 137 174 | ||||||
| 2021-09-03 | 2021-09-02 | 4 | KISNER DANIEL L | HSTO | Stock Option (right to buy) | D | 0,82 | 20 000 | 20 000 | |||||
| 2021-09-03 | 2021-09-02 | 4 | Jackson Jonathan | HSTO | Stock Option (right to buy) | D | 0,82 | 20 000 | 20 000 | |||||
| 2021-09-03 | 2021-09-02 | 4 | Crean David Hugh | HSTO | Stock Option (right to buy) | D | 0,82 | 25 000 | 25 000 | |||||
| 2021-09-03 | 2021-09-02 | 4 | Mento Steven J | HSTO | Stock Option (right to buy) | D | 0,82 | 20 000 | 20 000 | |||||
| 2021-09-03 | 2021-09-02 | 4 | Satz Brian | HSTO | Stock Option (right to buy) | D | 0,82 | 20 000 | 20 000 | |||||
| 2021-03-30 | 2021-03-30 | 4 | Pascoe Richard W | HSTO | Common Stock | D | 1,1400 | 20 000 | 23 | 30 000 | ||||
| 2021-03-26 | 2021-03-25 | 4 | Fuhrmann Rochelle | HSTO | Stock Option (right to buy) | D | 1,27 | 30 000 | 30 000 | |||||
| 2021-03-12 | 2021-03-10 | 4 | Windham-Bannister Susan Richards | HSTO | Stock Option (right to buy) | D | 1,23 | 30 000 | 30 000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Pascoe Richard W | HSTO | Stock Option (right to buy) | D | 0,97 | 346 000 | 346 000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Naughton Gail K | HSTO | Stock Option (right to buy) | D | 0,97 | 95 000 | 95 000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Latterich Martin | HSTO | Stock Option (right to buy) | D | 0,97 | 90 000 | 90 000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Knudson Susan A. | HSTO | Stock Option (right to buy) | D | 0,97 | 112 000 | 112 000 | |||||
| 2021-01-15 | 2021-01-13 | 4 | Daniels Moya | HSTO | Stock Option (right to buy) | D | 0,97 | 100 000 | 100 000 | |||||
| 2020-12-07 | 2020-12-03 | 4 | Pascoe Richard W | HSTO | Common Stock | D | 1,2394 | 10 000 | 12 | 10 000 | ||||
| 2020-10-19 | 2020-10-16 | 4 | Daniels Moya | HSTO | Stock Option (right to buy) | D | 2,27 | 65 000 | 65 000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | Satz Brian | HSTO | Stock Option (right to buy) | D | 1,89 | 20 000 | 20 000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | Mento Steven J | HSTO | Stock Option (right to buy) | D | 1,89 | 20 000 | 20 000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | Zhang Yizhuo | HSTO | Stock Option (right to buy) | D | 1,89 | 20 000 | 20 000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | Crean David Hugh | HSTO | Stock Option (right to buy) | D | 1,89 | 20 000 | 20 000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | KISNER DANIEL L | HSTO | Stock Option (right to buy) | D | 1,89 | 20 000 | 20 000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | Jackson Jonathan | HSTO | Stock Option (right to buy) | D | 1,89 | 20 000 | 20 000 | |||||
| 2020-10-09 | 2020-10-07 | 4 | Chang Stephen | HSTO | Stock Option (right to buy) | D | 1,89 | 20 000 | 20 000 | |||||
| 2020-05-29 | 2020-05-28 | 4 | Knudson Susan A. | HSTO | Stock Option (right to buy) | D | 4,61 | 124 119 | 124 119 | |||||
| 2020-05-28 | 2018-05-02 | 4 | Crean David Hugh | HSTO | Stock Option (right to buy) | D | 3,84 | 35 855 | 35 855 | |||||
| 2020-05-28 | 2017-10-25 | 4 | Crean David Hugh | HSTO | Stock Option (right to buy) | D | 3,84 | 4 302 | 4 302 | |||||
| 2020-05-28 | 2017-05-22 | 4 | Crean David Hugh | HSTO | Stock Option (right to buy) | D | 3,70 | 17 210 | 17 210 | |||||
| 2020-05-28 | 2020-05-26 | 4 | Zhang Yizhuo | HSTO | Common Stock | I | 600 983 | 600 983 | ||||||
| 2020-05-28 | 2020-05-26 | 4 | Chang Stephen | HSTO | Common Stock | D | 14 485 | 14 485 | ||||||
| 2020-05-28 | 2018-05-02 | 4 | Chang Stephen | HSTO | Stock Option (right to buy) | D | 3,84 | 35 855 | 35 855 | |||||
| 2020-05-28 | 2016-01-29 | 4 | Chang Stephen | HSTO | Stock Option (right to buy) | D | 1,47 | 14 342 | 14 342 | |||||
| 2020-05-28 | 2020-05-26 | 4 | Jackson Jonathan | HSTO | Common Stock | I | 2 356 597 | 2 356 597 | ||||||
| 2020-05-28 | 2020-05-26 | 4 | Latterich Martin | HSTO | Common Stock | D | 11 951 | 11 951 | ||||||
| 2020-05-28 | 2018-03-12 | 4 | Latterich Martin | HSTO | Stock Option (right to buy) | D | 3,84 | 14 342 | 14 342 | |||||
| 2020-05-28 | 2016-10-07 | 4 | Latterich Martin | HSTO | Stock Option (right to buy) | D | 3,70 | 28 684 | 28 684 | |||||
| 2020-05-28 | 2020-05-26 | 4 | Satz Brian | HSTO | Common Stock | D | 1 434 | 1 434 | ||||||
| 2020-05-28 | 2018-05-02 | 4 | Satz Brian | HSTO | Stock Option (right to buy) | D | 3,84 | 35 855 | 35 855 | |||||
| 2020-05-28 | 2020-05-26 | 4 | Naughton Gail K | HSTO | Common Stock | I | 426 526 | 426 526 | ||||||
| 2020-05-28 | 2012-05-12 | 4 | Naughton Gail K | HSTO | Stock Option (right to buy) | D | 0,53 | 380 063 | 380 063 | |||||
| 2020-05-28 | 2019-01-24 | 4 | Pascoe Richard W | HSTO | Stock Option (right to buy) | D | 5,30 | 194 071 | 194 071 | |||||
| 2020-05-28 | 2019-01-24 | 4 | Pascoe Richard W | HSTO | Stock Option (right to buy) | D | 5,30 | 291 107 | 291 107 | |||||
| 2020-05-27 | 2020-05-22 | 4 | Mento Steven J | HSTO | Restricted Stock Units | D | −65 000 | 0 | ||||||
| 2020-05-27 | 2020-05-22 | 4 | Mento Steven J | HSTO | Common Stock | D | 0,5600 | −31 428 | −18 | 39 572 | ||||
| 2020-05-27 | 2020-05-22 | 4 | Mento Steven J | HSTO | Common Stock | D | 65 000 | 71 000 | ||||||
| 2020-05-27 | 2020-05-22 | 4 | Spada Alfred P. | HSTO | Restricted Stock Units | D | −31 343 | 0 | ||||||
| 2020-05-27 | 2020-05-22 | 4 | Spada Alfred P. | HSTO | Common Stock | D | 0,5600 | −12 960 | −7 | 19 595 | ||||
| 2020-05-27 | 2020-05-22 | 4 | Spada Alfred P. | HSTO | Common Stock | D | 31 343 | 32 555 | ||||||
| 2020-05-27 | 2020-05-22 | 4 | Marshall Keith W | HSTO | Restricted Stock Units | D | −38 500 | 0 | ||||||
| 2020-05-27 | 2020-05-22 | 4 | Marshall Keith W | HSTO | Common Stock | D | 0,5600 | −18 615 | −10 | 19 885 | ||||
| 2020-05-27 | 2020-05-22 | 4 | Marshall Keith W | HSTO | Common Stock | D | 38 500 | 38 500 | ||||||
| 2019-11-19 | 2019-11-18 | 4 | Scott Kathleen D. | CNAT | Stock Option (Right to Buy) | D | 0,33 | 30 000 | 30 000 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Marshall Keith W | CNAT | Restricted Stock Units | D | 385 000 | 385 000 | ||||||
| 2019-08-01 | 2019-08-01 | 4 | Marshall Keith W | CNAT | Stock Option (Right to Buy) | D | 2,00 | −175 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Marshall Keith W | CNAT | Stock Option (Right to Buy) | D | 5,17 | −70 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Marshall Keith W | CNAT | Stock Option (Right to Buy) | D | 5,74 | −525 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Restricted Stock Units | D | 313 436 | 313 436 | ||||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 2,00 | −175 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 5,17 | −70 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 4,21 | −100 625 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 1,85 | −21 875 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 1,85 | −109 375 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 6,40 | −100 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 9,45 | −50 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Restricted Stock Units | D | 86 375 | 86 375 | ||||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 2,00 | −50 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 5,17 | −16 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 4,21 | −23 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 2,09 | −20 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 1,85 | −3 750 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 1,85 | −15 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 9,61 | −15 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 6,40 | −15 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 9,45 | −15 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Restricted Stock Units | D | 650 000 | 650 000 | ||||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 2,00 | −350 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 5,17 | −120 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 4,21 | −172 500 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 1,85 | −37 500 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 1,85 | −20 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 6,40 | −50 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 6,40 | −150 000 | 0 | |||||
| 2019-08-01 | 2019-08-01 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 9,45 | −400 000 | 0 | |||||
| 2019-07-01 | 2019-06-27 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 0,29 | 45 000 | 45 000 | |||||
| 2019-07-01 | 2019-06-27 | 4 | KISNER DANIEL L | CNAT | Stock Option (Right to Buy) | D | 0,29 | 20 000 | 20 000 | |||||
| 2019-07-01 | 2019-06-27 | 4 | Klassen Preston | CNAT | Stock Option (Right to Buy) | D | 0,29 | 20 000 | 20 000 | |||||
| 2019-07-01 | 2019-06-27 | 4 | LARUE WILLIAM R | CNAT | Stock Option (Right to Buy) | D | 0,29 | 20 000 | 20 000 | |||||
| 2019-07-01 | 2019-06-27 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 0,29 | 20 000 | 20 000 | |||||
| 2019-02-11 | 2019-02-07 | 4 | RIPLEY DANIEL L. | CNAT | Stock Option (Right to Buy) | D | 2,00 | 100 000 | 100 000 | |||||
| 2019-02-11 | 2018-11-14 | 4 | RIPLEY DANIEL L. See footnote. | CNAT | Common Stock | I | 3,1500 | 1 861 | 6 | 32 431 | ||||
| 2019-02-11 | 2018-05-14 | 4 | RIPLEY DANIEL L. See footnote. | CNAT | Common Stock | I | 3,3100 | 1 290 | 4 | 30 570 | ||||
| 2019-02-11 | 2019-02-07 | 4 | Marshall Keith W | CNAT | Stock Option (Right to Buy) | D | 2,00 | 175 000 | 175 000 | |||||
| 2019-02-11 | 2019-02-07 | 4 | Smith Edward F III | CNAT | Stock Option (Right to Buy) | D | 2,00 | 100 000 | 100 000 | |||||
| 2019-02-11 | 2018-11-14 | 4 | Smith Edward F III | CNAT | Common Stock | D | 3,1500 | 1 724 | 5 | 10 875 | ||||
| 2019-02-11 | 2018-05-14 | 4 | Smith Edward F III | CNAT | Common Stock | D | 3,3100 | 4 690 | 16 | 9 151 | ||||
| 2019-02-11 | 2019-02-07 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 2,00 | 175 000 | 175 000 | |||||
| 2019-02-11 | 2019-02-07 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 2,00 | 50 000 | 50 000 | |||||
| 2019-02-11 | 2019-02-07 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 2,00 | 350 000 | 350 000 | |||||
| 2019-02-11 | 2019-02-07 | 4 | Hagerty David T | CNAT | Stock Option (Right to Buy) | D | 2,00 | 175 000 | 175 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | KISNER DANIEL L | CNAT | Stock Option (Right to Buy) | D | 4,99 | 20 000 | 20 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | Klassen Preston | CNAT | Stock Option (Right to Buy) | D | 4,99 | 20 000 | 20 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | LARUE WILLIAM R | CNAT | Stock Option (Right to Buy) | D | 4,99 | 20 000 | 20 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | Scopa James Paul | CNAT | Stock Option (Right to Buy) | D | 4,99 | 20 000 | 20 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 4,99 | 20 000 | 20 000 | |||||
| 2018-06-25 | 2018-06-21 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 4,99 | 45 000 | 45 000 | |||||
| 2018-05-07 | 2018-05-04 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 0,99 | −60 000 | 147 070 | |||||
| 2018-05-07 | 2018-05-04 | 4 | Mento Steven J | CNAT | Common Stock | D | 0,9900 | 60 000 | 59 | 60 000 | ||||
| 2018-03-01 | 2018-02-27 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 1,24 | −12 121 | 0 | |||||
| 2018-03-01 | 2018-02-27 | 4 | Spada Alfred P. | CNAT | Common Stock | D | 1,2400 | 12 121 | 15 | 12 121 | ||||
| 2018-02-05 | 2017-05-30 | 5 | VANDERTIE MICHELLE L See footnote. | CNAT | Common Stock | I | −2 165 | 2 813 | ||||||
| 2018-02-05 | 2018-02-04 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 5,17 | 120 000 | 120 000 | |||||
| 2018-02-05 | 2018-02-04 | 4 | Hagerty David T | CNAT | Stock Option (Right to Buy) | D | 5,17 | 70 000 | 70 000 | |||||
| 2018-02-05 | 2018-02-04 | 4 | Marshall Keith W | CNAT | Stock Option (Right to Buy) | D | 5,17 | 70 000 | 70 000 | |||||
| 2018-02-05 | 2018-02-04 | 4 | RIPLEY DANIEL L. | CNAT | Stock Option (Right to Buy) | D | 5,17 | 40 000 | 40 000 | |||||
| 2018-02-05 | 2017-11-14 | 4 | RIPLEY DANIEL L. See footnote. | CNAT | Common Stock | I | 3,4800 | 818 | 3 | 29 280 | ||||
| 2018-02-05 | 2017-05-12 | 4 | RIPLEY DANIEL L. See footnote. | CNAT | Common Stock | I | 1,7000 | 761 | 1 | 28 462 | ||||
| 2018-02-05 | 2018-02-04 | 4 | Smith Edward F III | CNAT | Stock Option (Right to Buy) | D | 5,17 | 40 000 | 40 000 | |||||
| 2018-02-05 | 2017-11-14 | 4 | Smith Edward F III | CNAT | Common Stock | D | 3,4800 | 4 461 | 16 | 4 461 | ||||
| 2018-02-05 | 2018-02-04 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 5,17 | 70 000 | 70 000 | |||||
| 2018-02-05 | 2018-02-04 | 4 | VANDERTIE MICHELLE L | CNAT | Stock Option (Right to Buy) | D | 5,17 | 16 000 | 16 000 | |||||
| 2017-09-01 | 2017-08-31 | 4 | Marshall Keith W | CNAT | Stock Option (Right to Buy) | D | 5,74 | 525 000 | 525 000 | |||||
| 2017-06-26 | 2017-06-22 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 4,96 | 20 000 | 20 000 | |||||
| 2017-06-26 | 2017-06-22 | 4 | KISNER DANIEL L | CNAT | Stock Option (Right to Buy) | D | 4,96 | 20 000 | 20 000 | |||||
| 2017-06-26 | 2017-06-22 | 4 | Klassen Preston | CNAT | Stock Option (Right to Buy) | D | 4,96 | 20 000 | 20 000 | |||||
| 2017-06-26 | 2017-06-22 | 4 | Scopa James Paul | CNAT | Stock Option (Right to Buy) | D | 4,96 | 20 000 | 20 000 | |||||
| 2017-06-26 | 2017-06-22 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 4,96 | 45 000 | 45 000 | |||||
| 2017-04-07 | 3 | VANDERTIE MICHELLE L See footnote. | CNAT | Common Stock | I | 9 956 | ||||||||
| 2017-04-07 | 3 | VANDERTIE MICHELLE L See footnote. | CNAT | Common Stock | I | 9 956 | ||||||||
| 2017-02-07 | 2017-02-06 | 4 | LARUE WILLIAM R | CNAT | Stock Option (Right to Buy) | D | 5,09 | 30 000 | 30 000 | |||||
| 2017-02-02 | 3 | RIPLEY DANIEL L. See footnote. | CNAT | Common Stock | I | 55 402 | ||||||||
| 2017-02-02 | 3 | RIPLEY DANIEL L. See footnote. | CNAT | Common Stock | I | 55 402 | ||||||||
| 2017-02-02 | 2017-01-26 | 4 | RIPLEY DANIEL L. | CNAT | Stock Option (Right to Buy) | D | 4,21 | 73 000 | 73 000 | |||||
| 2017-02-01 | 2017-01-26 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 4,21 | 172 500 | 172 500 | |||||
| 2017-02-01 | 2017-01-26 | 4 | Cashion Charles | CNAT | Stock Option (Right to Buy) | D | 4,21 | 57 500 | 57 500 | |||||
| 2017-02-01 | 2017-01-26 | 4 | Hagerty David T | CNAT | Stock Option (Right to Buy) | D | 4,21 | 100 625 | 100 625 | |||||
| 2017-02-01 | 2017-01-26 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 4,21 | 100 625 | 100 625 | |||||
| 2017-02-01 | 2017-01-26 | 4 | Smith Edward F III | CNAT | Stock Option (Right to Buy) | D | 4,21 | 57 500 | 57 500 | |||||
| 2017-01-11 | 2017-01-09 | 4 | Cashion Charles | CNAT | Stock Option (Right to Buy) | D | 0,99 | −42 424 | 0 | |||||
| 2017-01-11 | 2017-01-09 | 4 | Cashion Charles | CNAT | Common Stock | D | 0,9900 | 42 424 | 42 | 42 424 | ||||
| 2016-12-30 | 2014-02-19 | 4/A | KISNER DANIEL L | CNAT | Common Stock | I | 3 145 | 3 145 | ||||||
| 2016-12-30 | 2016-12-28 | 4 | KISNER DANIEL L | CNAT | Common Stock | I | 2 310 | 5 455 | ||||||
| 2016-12-22 | 2016-12-20 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 0,99 | −5 051 | 207 070 | |||||
| 2016-12-22 | 2016-12-20 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 1,24 | −36 363 | 0 | |||||
| 2016-12-22 | 2016-12-20 | 4 | Mento Steven J | CNAT | Common Stock | D | 0,9900 | 5 051 | 5 | 41 414 | ||||
| 2016-12-22 | 2016-12-20 | 4 | Mento Steven J | CNAT | Common Stock | D | 1,2400 | 36 363 | 45 | 36 363 | ||||
| 2016-10-31 | 2016-10-27 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 0,25 | −18 181 | 0 | |||||
| 2016-10-31 | 2016-10-27 | 4 | Van Wart Harold | CNAT | Common Stock | D | 0,2500 | 18 181 | 5 | 18 181 | ||||
| 2016-06-27 | 2016-06-23 | 4 | Malik Shahzad | CNAT | Stock Option (Right to Buy) | D | 2,13 | 20 000 | 20 000 | |||||
| 2016-06-24 | 2016-06-23 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 2,13 | 45 000 | 45 000 | |||||
| 2016-06-24 | 2016-06-23 | 4 | KISNER DANIEL L | CNAT | Stock Option (Right to Buy) | D | 2,13 | 20 000 | 20 000 | |||||
| 2016-06-24 | 2016-06-23 | 4 | Scopa James Paul | CNAT | Stock Option (Right to Buy) | D | 2,13 | 20 000 | 20 000 | |||||
| 2016-06-24 | 2016-06-23 | 4 | Klassen Preston | CNAT | Stock Option (Right to Buy) | D | 2,13 | 20 000 | 20 000 | |||||
| 2016-06-24 | 2016-06-23 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 2,13 | 20 000 | 20 000 | |||||
| 2016-04-04 | 2016-04-01 | 4 | Smith Edward F III | CNAT | Stock Option (Right to Buy) | D | 2,53 | 100 000 | 100 000 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 1,85 | 37 500 | 37 500 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 1,85 | 187 500 | 187 500 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Cashion Charles | CNAT | Stock Option (Right to Buy) | D | 1,85 | 12 500 | 12 500 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Cashion Charles | CNAT | Stock Option (Right to Buy) | D | 1,85 | 50 000 | 50 000 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Hagerty David T | CNAT | Stock Option (Right to Buy) | D | 1,85 | 21 875 | 21 875 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Hagerty David T | CNAT | Stock Option (Right to Buy) | D | 1,85 | 109 375 | 109 375 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 1,85 | 21 875 | 21 875 | |||||
| 2016-02-08 | 2016-02-04 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 1,85 | 109 375 | 109 375 | |||||
| 2015-06-15 | 2015-06-11 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 5,52 | 35 000 | 35 000 | |||||
| 2015-06-15 | 2015-06-11 | 4 | KISNER DANIEL L | CNAT | Stock Option (Right to Buy) | D | 5,52 | 15 000 | 15 000 | |||||
| 2015-06-15 | 2015-06-11 | 4 | LACASSE LOUIS P | CNAT | Stock Option (Right to Buy) | D | 5,52 | 15 000 | 15 000 | |||||
| 2015-06-15 | 2015-06-11 | 4 | Malik Shahzad | CNAT | Stock Option (Right to Buy) | D | 5,52 | 15 000 | 15 000 | |||||
| 2015-06-15 | 2015-06-11 | 4 | Scopa James Paul | CNAT | Stock Option (Right to Buy) | D | 5,52 | 15 000 | 15 000 | |||||
| 2015-06-15 | 2015-06-11 | 4 | Klassen Preston | CNAT | Stock Option (Right to Buy) | D | 5,52 | 15 000 | 15 000 | |||||
| 2015-06-15 | 2015-06-11 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 5,52 | 15 000 | 15 000 | |||||
| 2015-04-10 | 2015-04-08 | 4 | KISNER DANIEL L | CNAT | Common Stock | D | 5,7500 | 4 000 | 23 | 7 145 | ||||
| 2015-02-25 | 2015-02-23 | 4 | Cashion Charles | CNAT | Stock Option (Right to Buy) | D | 6,40 | 50 000 | 50 000 | |||||
| 2015-02-25 | 2015-02-23 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 6,40 | 50 000 | 50 000 | |||||
| 2015-02-25 | 2015-02-23 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 6,40 | 150 000 | 150 000 | |||||
| 2015-02-25 | 2015-02-23 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 6,40 | 100 000 | 100 000 | |||||
| 2015-02-06 | 2014-04-02 | 5 | Cashion Charles See footnote. | CNAT | Common Stock | I | −5 000 | 144 738 | ||||||
| 2014-10-03 | 2014-10-01 | 4 | Hagerty David T | CNAT | Stock Option (Right to Buy) | D | 5,92 | 175 000 | 175 000 | |||||
| 2014-06-23 | 2014-06-19 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 7,97 | 35 000 | 35 000 | |||||
| 2014-06-23 | 2014-06-19 | 4 | LACASSE LOUIS P | CNAT | Stock Option (Right to Buy) | D | 7,97 | 15 000 | 15 000 | |||||
| 2014-06-23 | 2014-06-19 | 4 | Malik Shahzad | CNAT | Stock Option (Right to Buy) | D | 7,97 | 15 000 | 15 000 | |||||
| 2014-06-23 | 2014-06-19 | 4 | Scopa James Paul | CNAT | Stock Option (Right to Buy) | D | 7,97 | 15 000 | 15 000 | |||||
| 2014-06-23 | 2014-06-19 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 7,97 | 15 000 | 15 000 | |||||
| 2014-02-25 | 2014-02-19 | 4 | KISNER DANIEL L | CNAT | Common Stock | D | 3 145 | 3 145 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | Aberdare GP III, L.L.C. By Aberdare GP III, L.L.C. | CNAT | Common Stock | I | −36 634 | 0 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | Aberdare GP III, L.L.C. By Aberdare GP III, L.L.C. | CNAT | Common Stock | I | 36 634 | 36 634 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Common Stock | I | −30 216 | 22 203 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | −1 283 589 | 943 355 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | KLINGENSTEIN PAUL H By Klingenstein-Bole 2003 Irrevocable Children's Trust | CNAT | Common Stock | I | 8 731 | 8 731 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | KLINGENSTEIN PAUL H | CNAT | Common Stock | D | 20 322 | 20 322 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | KLINGENSTEIN PAUL H By Aberdare GP III, L.L.C. | CNAT | Common Stock | I | −36 634 | 0 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | KLINGENSTEIN PAUL H By Aberdare GP III, L.L.C. | CNAT | Common Stock | I | 36 634 | 36 634 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | −30 216 | 22 203 | ||||||
| 2014-02-25 | 2014-02-19 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | −1 283 589 | 943 355 | ||||||
| 2014-02-11 | 2014-02-07 | 4 | KISNER DANIEL L | CNAT | Stock Option (Right to Buy) | D | 9,45 | 30 000 | 30 000 | |||||
| 2014-02-11 | 2014-02-07 | 4 | Mento Steven J | CNAT | Stock Option (Right to Buy) | D | 9,45 | 400 000 | 400 000 | |||||
| 2014-02-11 | 2014-02-07 | 4 | Cashion Charles | CNAT | Stock Option (Right to Buy) | D | 9,45 | 50 000 | 50 000 | |||||
| 2014-02-11 | 2014-02-07 | 4 | Klassen Preston | CNAT | Stock Option (Right to Buy) | D | 9,45 | 30 000 | 30 000 | |||||
| 2014-02-11 | 2014-02-07 | 4 | Spada Alfred P. | CNAT | Stock Option (Right to Buy) | D | 9,45 | 50 000 | 50 000 | |||||
| 2014-02-11 | 2014-02-07 | 4 | BURGESS GARY C. | CNAT | Stock Option (Right to Buy) | D | 9,45 | 50 000 | 50 000 | |||||
| 2014-01-10 | 2014-01-08 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 0,99 | −12 121 | 0 | |||||
| 2014-01-10 | 2014-01-08 | 4 | HALE DAVID F | CNAT | Common Stock | D | 0,9900 | 12 121 | 12 | 24 242 | ||||
| 2013-09-27 | 2013-09-26 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 2,31 | −12 121 | 0 | |||||
| 2013-09-27 | 2013-09-26 | 4 | HALE DAVID F | CNAT | Common Stock | D | 2,3100 | 12 121 | 28 | 12 121 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Stock Option (Right to Buy) | D | 11,00 | 30 000 | 30 000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Warrant to Purchase Common Stock (Right to Buy) | I | 7,43 | 32 220 | 32 220 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Warrant to Purchase Series B Preferred Stock (Right to Buy) | I | 0,90 | −265 837 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Series B Convertible Preferred Stock | I | −8 333 334 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Common Stock | I | 11,0000 | 165 265 | 1 818 | 1 192 080 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Common Stock | I | 11,0000 | 16 716 | 184 | 1 026 815 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Scopa James Paul | CNAT | Common Stock | I | 1 010 099 | 1 010 099 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP See footnotes | CNAT | Warrants to Purchase Shares of Series A Preferred Stock | I | −577 599 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP See footnotes | CNAT | Series B Preferred Stock | I | −5 576 786 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP See footnotes | CNAT | Series A Preferred Stock | I | −10 000 000 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP See footnotes | CNAT | Common Stock | I | 11,0000 | 190 054 | 2 091 | 2 166 836 | ||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP | CNAT | Common Stock | I | 11,0000 | 19 223 | 211 | 1 976 782 | ||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP | CNAT | Common Stock | I | 11,0000 | −535 | −6 | 1 957 559 | ||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP | CNAT | Common Stock | I | 0,0825 | 70 003 | 6 | 1 958 094 | ||||
| 2013-08-01 | 2013-07-30 | 4 | ADVENT VENTURE PARTNERS LLP See footnotes | CNAT | Common Stock | I | 1 888 091 | 1 888 091 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | HALE DAVID F | CNAT | Stock Option (Right to Buy) | D | 11,00 | 50 000 | 50 000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | HALE DAVID F | CNAT | Series A Preferred Stock | I | −162 356 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | HALE DAVID F | CNAT | Common Stock | I | 11,0000 | 2 588 | 28 | 143 739 | ||||
| 2013-08-01 | 2013-07-30 | 4 | HALE DAVID F | CNAT | Common Stock | I | 11,0000 | 261 | 3 | 141 151 | ||||
| 2013-08-01 | 2013-07-30 | 4 | HALE DAVID F | CNAT | Common Stock | I | 19 679 | 140 890 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | LACASSE LOUIS P | CNAT | Stock Option (Right to Buy) | D | 11,00 | 30 000 | 30 000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | LACASSE LOUIS P | CNAT | Series B Preferred Stock | I | −5 555 556 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | LACASSE LOUIS P | CNAT | Common Stock | I | 11,0000 | 123 950 | 1 363 | 809 887 | ||||
| 2013-08-01 | 2013-07-30 | 4 | LACASSE LOUIS P | CNAT | Common Stock | I | 11,0000 | 12 537 | 138 | 685 937 | ||||
| 2013-08-01 | 2013-07-30 | 4 | LACASSE LOUIS P | CNAT | Common Stock | I | 673 400 | 673 400 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad | CNAT | Stock Option (Right to Buy) | D | 11,00 | 30 000 | 30 000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad See footnotes | CNAT | Warrants to Purchase Shares of Series A Preferred Stock | I | −577 599 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad See footnotes | CNAT | Series B Preferred Stock | I | −5 576 786 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad See footnotes | CNAT | Series A Preferred Stock | I | −10 000 000 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad | CNAT | Common Stock | I | 11,0000 | 190 054 | 2 091 | 2 166 836 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad | CNAT | Common Stock | I | 11,0000 | 19 223 | 211 | 1 976 782 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad | CNAT | Common Stock | I | 11,0000 | −535 | −6 | 1 957 559 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad | CNAT | Common Stock | I | 0,0825 | 70 003 | 6 | 1 958 094 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Malik Shahzad See footnotes | CNAT | Common Stock | I | 1 888 091 | 1 888 091 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Mento Steven J | CNAT | Series A Preferred Stock | I | −786 417 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Mento Steven J | CNAT | Common Stock | I | 11,0000 | 13 800 | 152 | 385 669 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Mento Steven J | CNAT | Common Stock | I | 11,0000 | 1 395 | 15 | 371 869 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Mento Steven J | CNAT | Common Stock | I | 95 323 | 370 474 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Cashion Charles | CNAT | Series A Preferred Stock | I | −355 352 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Cashion Charles | CNAT | Common Stock | I | 43 072 | 149 738 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier | CNAT | Stock Option (Right to Buy) | D | 11,00 | 30 000 | 30 000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Warrants to Purchase Shares of Series A Preferred Stock | I | −385 070 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Series B Preferred Stock | I | −3 717 861 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Series A Preferred Stock | I | −6 666 668 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Common Stock | I | 11,0000 | 165 525 | 1 821 | 1 487 320 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Common Stock | I | 11,0000 | 16 742 | 184 | 1 321 795 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Common Stock | I | 11,0000 | −352 | −4 | 1 305 053 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Common Stock | I | 46 675 | 1 305 405 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Perret Marc Olivier See footnotes | CNAT | Common Stock | I | 1 258 730 | 1 258 730 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | EVNIN LUKE | CNAT | Warrant to Purchase Common Stock (Right to Buy) | I | 7,43 | 32 220 | 32 220 | |||||
| 2013-08-01 | 2013-07-30 | 4 | EVNIN LUKE | CNAT | Warrant to Purchase Series B Preferred Stock (Right to Buy) | I | 0,90 | −265 837 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | EVNIN LUKE | CNAT | Series B Convertible Preferred Stock | I | −8 333 334 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | EVNIN LUKE | CNAT | Common Stock | I | 11,0000 | 165 265 | 1 818 | 1 192 080 | ||||
| 2013-08-01 | 2013-07-30 | 4 | EVNIN LUKE | CNAT | Common Stock | I | 11,0000 | 16 716 | 184 | 1 026 815 | ||||
| 2013-08-01 | 2013-07-30 | 4 | EVNIN LUKE | CNAT | Common Stock | I | 1 010 099 | 1 010 099 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | MPM BioVentures IV QP LP | CNAT | Warrant to Purchase Common Stock (Right to Buy) | I | 7,43 | 32 220 | 32 220 | |||||
| 2013-08-01 | 2013-07-30 | 4 | MPM BioVentures IV QP LP | CNAT | Warrant to Purchase Series B Preferred Stock (Right to Buy) | I | 0,90 | −265 837 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | MPM BioVentures IV QP LP | CNAT | Series B Convertible Preferred Stock | I | −8 333 334 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | MPM BioVentures IV QP LP | CNAT | Common Stock | I | 11,0000 | 165 265 | 1 818 | 1 192 080 | ||||
| 2013-08-01 | 2013-07-30 | 4 | MPM BioVentures IV QP LP | CNAT | Common Stock | I | 11,0000 | 16 716 | 184 | 1 026 815 | ||||
| 2013-08-01 | 2013-07-30 | 4 | MPM BioVentures IV QP LP | CNAT | Common Stock | I | 1 010 099 | 1 010 099 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Spada Alfred P. | CNAT | Series A Preferred Stock | I | −363 927 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Spada Alfred P. | CNAT | Common Stock | I | 44 112 | 235 021 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Van Wart Harold | CNAT | Stock Option (Right to Buy) | D | 11,00 | 30 000 | 30 000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Warrants to Purchase Shares of Series A Preferred Stock | D | −385 070 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Series B Preferred Stock | D | −3 717 861 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Series A Preferred Stock | D | −6 666 668 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Common Stock | D | 11,0000 | 165 525 | 1 821 | 1 487 320 | ||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Common Stock | D | 11,0000 | 16 742 | 184 | 1 321 795 | ||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Common Stock | D | 11,0000 | −352 | −4 | 1 305 053 | ||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Common Stock | D | 46 675 | 1 305 405 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | COOPERATIVE GILDE HEALTHCARE II U.A. | CNAT | Common Stock | D | 1 258 730 | 1 258 730 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 7,43 | 120 | 120 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Series B Preferred Stock | I | 0,90 | −997 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | −1 727 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | 1 727 | 1 727 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | −5 701 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | −8 552 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Series B Preferred Stock | I | −137 626 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Series A Preferred Stock | I | −246 775 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 7,43 | 5 131 | 5 131 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,90 | −42 336 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | −73 395 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | 73 395 | 73 395 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | −242 205 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | −363 308 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Series B Preferred Stock | I | −5 846 236 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Series A Preferred Stock | I | −10 483 166 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 11,0000 | 2 470 | 27 | 52 419 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 11,0000 | 251 | 3 | 49 949 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 11,0000 | −14 | −0 | 49 698 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 0,0825 | 1 727 | 0 | 49 712 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 46 594 | 47 985 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 11,0000 | 104 952 | 1 154 | 2 226 944 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 11,0000 | 10 614 | 117 | 2 121 992 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 11,0000 | −552 | −6 | 2 111 378 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 0,0825 | 73 395 | 6 | 2 111 930 | ||||
| 2013-08-01 | 2013-07-30 | 4 | Aberdare GP III, L.L.C. By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 1 979 321 | 2 038 535 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H | CNAT | Stock Option (right to buy) | D | 11,00 | 30 000 | 30 000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 7,43 | 120 | 120 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Series B Preferred Stock | I | 0,90 | −997 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | −1 727 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | 1 727 | 1 727 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | −5 701 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | −8 552 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Series B Preferred Stock | I | −137 626 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Series A Preferred Stock | I | −246 775 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 7,43 | 5 131 | 5 131 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,90 | −42 336 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | −73 395 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Common Stock | I | 0,08 | 73 395 | 73 395 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | −242 205 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Warrant to Purchase Series A Preferred Stock | I | 0,01 | −363 308 | 0 | |||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Series B Preferred Stock | I | −5 846 236 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Series A Preferred Stock | I | −10 483 166 | 0 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 11,0000 | 2 470 | 27 | 52 419 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 11,0000 | 251 | 3 | 49 949 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 11,0000 | −14 | −0 | 49 698 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 0,0825 | 1 727 | 0 | 49 712 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 46 594 | 47 985 | ||||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 11,0000 | 104 952 | 1 154 | 2 226 944 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 11,0000 | 10 614 | 117 | 2 121 992 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 11,0000 | −552 | −6 | 2 111 378 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 0,0825 | 73 395 | 6 | 2 111 930 | ||||
| 2013-08-01 | 2013-07-30 | 4 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 1 979 321 | 2 038 535 | ||||||
| 2013-07-24 | 3 | HALE DAVID F | CNAT | Common Stock | I | 121 211 | ||||||||
| 2013-07-24 | 3 | Mento Steven J | CNAT | Common Stock | I | 275 151 | ||||||||
| 2013-07-24 | 3 | Cashion Charles | CNAT | Common Stock | I | 106 666 | ||||||||
| 2013-07-24 | 3 | Spada Alfred P. | CNAT | Common Stock | I | 190 909 | ||||||||
| 2013-07-24 | 3 | BURGESS GARY C. | CNAT | Common Stock | D | 121 212 | ||||||||
| 2013-07-24 | 3 | Aberdare Partners III LP By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 1 391 | ||||||||
| 2013-07-24 | 3 | Aberdare Partners III LP By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 59 214 | ||||||||
| 2013-07-24 | 3 | KLINGENSTEIN PAUL H By Aberdare Partners III, L.P. | CNAT | Common Stock | I | 1 391 | ||||||||
| 2013-07-24 | 3 | KLINGENSTEIN PAUL H By Aberdare Ventures III, L.P. | CNAT | Common Stock | I | 59 214 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
